0 Bewertungen0% fanden dieses Dokument nützlich (0 Abstimmungen)
870 Ansichten2 Seiten
This medication card provides information on vitamin D3 (cholecalciferol) tablets. Vitamin D3 is classified as a vitamin and works to promote calcium absorption in the intestines after activation in the liver and kidneys. The indicated dose for this patient of 4000 units daily is not considered safe. Nursing considerations for vitamin D3 administration include monitoring for signs of toxicity like hypercalcemia and ensuring appropriate dietary intake of calcium and vitamin D.
This medication card provides information on vitamin D3 (cholecalciferol) tablets. Vitamin D3 is classified as a vitamin and works to promote calcium absorption in the intestines after activation in the liver and kidneys. The indicated dose for this patient of 4000 units daily is not considered safe. Nursing considerations for vitamin D3 administration include monitoring for signs of toxicity like hypercalcemia and ensuring appropriate dietary intake of calcium and vitamin D.
This medication card provides information on vitamin D3 (cholecalciferol) tablets. Vitamin D3 is classified as a vitamin and works to promote calcium absorption in the intestines after activation in the liver and kidneys. The indicated dose for this patient of 4000 units daily is not considered safe. Nursing considerations for vitamin D3 administration include monitoring for signs of toxicity like hypercalcemia and ensuring appropriate dietary intake of calcium and vitamin D.
Generic name of medication Brand/trade name of medication
cholecalciferol, TAB vitamin D3 (inactive)
Drug classification (i.e. beta blocker, etc) 1. Patient dose
4000 unit, PO vitamins 2. Safe dose ranges
PO: (Adults) 400–1000 IU daily.
PO: Infants Exclusively or partially-
breastfed- 400 IU daily.
3. Is the dose safe
No
Therapeutic effect (i.e. decreased heart rate, Indication in this patient
etc) and when it should develop Vitamin D deficiency Requires activation in the liver and kidneys to create the active form of vitamin D3 (calcitriol). Promotes the intestinal absorption of dietary calcium.
Therapeutic Effect(s):
Treatment and prevention of deficiency states,
particularly bone manifestations.
Pre and post administration assessment Unique nursing considerations
Assess vitamin deficiency before and during
Contraindicated in: therapy. Assess patient for bone pain and weakness before and during therapy. Observe Hypersensitivity patient carefully for evidence of hypocalcemia Hypercalcemia (paresthesia, muscle twitching, laryngospasm, Vitamin D toxicity colic, cardiac arrhythmias, and Chvostek's or Concurrent use of magnesium- Trousseau's sign). Protect symptomatic patient containing antacids or other vitamin D by raising and padding side rails; keep bed in supplements low position. Monitor serum calcium, Malabsorption problems. phosphorus, and alkaline phosphatase Use Cautiously in: periodically. OB: Safety not established.
Adverse effects/minimizing discomfort and Key patient teaching points
harm Advise patient to take medication as Seen primarily as manifestations of toxicity directed. Take missed doses as soon (hypercalcemia) as remembered that day, unless almost time for next dose; do not CNS: headache, irritability, somnolence, double up on doses. Advise parents to weakness use calibrated measuring device or dropper with oral solution. EENT: conjunctivitis, photophobia Review diet modifications with patient. See food sources for specific CV: arrhythmias, hypertension nutrients for foods high in calcium and vitamin D. GI: anorexia, constipation, dry mouth, ↑ liver Encourage patient to comply with enzymes, metallic taste, nausea, dietary recommendations of health PANCREATITIS, polydipsia, vomiting, care professional. Explain that the weight loss best source of vitamins is a well- balanced diet with foods from the 4 GU: albuminuria, azotemia, polyuria basic food groups and the importance of sunlight exposure. Derm: pruritus Patients self-medicating with vitamin supplements should be cautioned not F and E: hypercalcemia to exceed RDA. The effectiveness of megadoses for treatment of various MS: bone pain, muscle pain medical conditions is unproved and may cause side effects. * CAPITALS indicate life-threatening. Advise patient to avoid concurrent use of antacids containing magnesium. Review symptoms of overdose and instruct patient to report these promptly to health care professional. Emphasize the importance of follow- up exams to evaluate progress.